BIONUMERIK PHARMACEUTICALS, INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 74181
 
  
 
C07D HETEROCYCLIC COMPOUNDS 10152
 
  
 
C07F ACYCLIC, CARBOCYCLIC, OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM, OR TELLURIUM 961
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 689
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 544
 
  
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 4134
 
  
 
C07K PEPTIDES 1135
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 1124
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 1205
 
  
 
G06N COMPUTER SYSTEMS BASED ON SPECIFIC COMPUTATIONAL MODELS 165

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0007,561 CONTEMPORANEOUS, HETEROGENEOUSLY-ORIENTED, MULTI-TARGETED THERAPEUTIC MODIFICATION AND/OR MODULATION OF DISEASE BY ADMINISTRATION OF SULFUR-CONTAINING, AMINO ACID-SPECIFIC SMALL MOLECULESAug 08, 14Jan 12, 17[A61K, C12Q, G01N, C07K]
2016/0038,519 ADMINISTRATION OF KARENITECIN FOR THE TREATMENT OF ADVANCED OVARIAN CANCER, INCLUDING CHEMOTHERAPY-RESISTANT AND/OR THE MUCINOUS ADENOCARCINOMA SUB-TYPESAug 08, 14Feb 11, 16[A61K]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9320760 Compositions and methods of use of compounds to increase cancer patient survival timeJul 15, 08Apr 26, 16[A61K, G01N]
9023805 Increasing cancer patient survival time by administration of dithio-containing compoundsSep 16, 10May 05, 15[A61K]
8722886 Methods for the total chemical synthesis of enantiomerically-pure 7-(2′-trimethylsilyl)ethyl camptothecinNov 13, 12May 13, 14[C07F, C07D]
8710095 Drugs for prophylaxis or mitigation of taxane-induced neurotoxicityApr 30, 02Apr 29, 14[A61K, A01N]
8569265 Deuterated analogs of (4S)-4-ethyl-4-hydroxy-11-[2- (trimethylsilyl)ethyl]-1H-pyrano[3′, 4′:6,7] indolizino [1,2-b]quinoline-3,14(4H, 12H)-dione and methods of use thereofMay 06, 11Oct 29, 13[A61K, C07F]
8143236 Chemoprotective methodsMar 14, 08Mar 27, 12[A61K]
7829117 Compounds and methods for reducing undesired toxicity of chemotherapeutic agentsNov 14, 07Nov 09, 10[A61K]
7829538 Compounds and methods for reducing undesired toxicity of chemotherapeutic agentsNov 14, 07Nov 09, 10[A61K]
7829539 Compounds and methods for reducing undesired toxicity of chemotherapeutic agentsNov 14, 07Nov 09, 10[A61K]
7829540 Compounds and methods for reducing undesired toxicity of chemotherapeutic agentsNov 14, 07Nov 09, 10[A61K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2016/0287,540 Increasing Cancer Patient Survival Time by Administration of Dithio-Containing CompoundsAbandonedMar 31, 15Oct 06, 16[A61K]
2014/0073,793 Germanium-containing camptothecin analoguesAbandonedSep 07, 12Mar 13, 14[C07F]
8026227 Chemoprotective methods and compositionsExpiredDec 13, 06Sep 27, 11[A61K]
2009/0232,906 Treatment methods and compositions for lung cancer, adenocarcinoma, and other medical conditionsAbandonedMar 14, 08Sep 17, 09[A61K, A61P]
7569606 Platinum complexes with mononitrile-containing ligandsExpiredApr 17, 06Aug 04, 09[A61K, C07F]
2009/0111,735 Compounds and methods for reducing undesired toxicity of chemotherapeutic agentsAbandonedSep 17, 08Apr 30, 09[A61K, A61P]
2007/0219,268 Anti-cancer activity augmentation compounds and formulations and methods of use thereofAbandonedMar 16, 07Sep 20, 07[A61K]
7238823 Platinum complexes with mononitrile-containing ligandsExpiredJan 26, 06Jul 03, 07[C07F]
2006/0094,692 Pharmaceutical formulations of camptothecins and process for making sameAbandonedOct 28, 04May 04, 06[A61K]
2006/0063,742 Method of treatment for or protection against lymphedemaAbandonedSep 21, 04Mar 23, 06[A61K]
6977311 Process for synthesizing L-γ-methylene glutamic acid and analogsExpiredJul 25, 03Dec 20, 05[C07D, C07C]
2005/0256,055 Compounds and methods for reducing undesired toxicity of chemotherapeutic agentsAbandonedMay 12, 04Nov 17, 05[A61K]
2004/0152,774 Method of protecing against tissue extra vasation injuryAbandonedFeb 04, 03Aug 05, 04[A61K]
2004/0092,739 Process for synthesizing antifolatesAbandonedJul 25, 03May 13, 04[C07D]
2004/0014,730 Formulations and methods of reducing toxicity of anti-infective agentsAbandonedJul 10, 02Jan 22, 04[A61K]
2003/0181,635 Process for coupling amino acids to an antifolate scaffoldAbandonedMar 22, 02Sep 25, 03[C07D, C07K]
6468993 Method for reducing development of osteoporosisExpiredOct 04, 99Oct 22, 02[A61K]
6352979 Method of treating snakebite and complications resulting therefromExpiredAug 20, 01Mar 05, 02[A61K]
6291441 Method of treating inflammatory bowel disordersExpiredSep 27, 00Sep 18, 01[A61K]
6274622 Method of treating diabetic ophthalmopathyExpiredOct 27, 99Aug 14, 01[A61K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.